In the quest to improve patient outcomes, life sciences companies are increasing their focus on optimizing the patient...
If you’re a life science marketer, chances are you’ve been hearing about the difference artificial...
Pharma manufacturers work relentlessly to create drugs and therapies to address some of the most complex health conditions people face. There are years of research and...
Innovate4Outcomes® was born in 2020 as a design-thinking event in response to COVID-19, but it quickly became clear the COVID-19 health crisis could be a catalyst for a...
At the recent Re:Imagine Pharma Marketing virtual conference, I was excited to present on how...
In our series on the challenges MS patients face in starting and staying on therapy, we’ve explored three key areas...
In our first two blog posts on challenges related to multiple sclerosis (MS) treatment, we addressed the need to build awareness...
In our initial blog post on challenges related to multiple sclerosis (MS) treatments, we discussed the first barrier, which is...
When it comes to multiple sclerosis (MS), there are multiple challenges that can deter patients from receiving the care they...
With COVID-19 still impacting provider facetime for brand field teams, life sciences organizations need new ways to deliver information that supports HCP awareness. That’s...
Omnichannel marketing continues to be a hot topic among pharma brand teams, but too often I see our clients struggling to convert their tactics and strategies into a true...
An astounding 7,000 rare and orphan diseases affect more than 30 million people in the United States alone1. Rare diseases are classified as any disease that affects less...
